Letter: Rifampicin in co-oncogenic experiments.
D000818:Animals; D004357:Drug Synergism; D007279:Injections, Subcutaneous; D008748:Methylcholanthrene / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D012293:Rifampin / Q000494:pharmacology*; D013997:Time Factors
D008748:Methylcholanthrene; D012293:Rifampin